Progesterone Raw Material Powder For Maintaining Pregnancy CAS:57-83-0

    What is Progesterone Raw Material Powder?

     Progesterone Raw Material Powder is the pure, unadulterated, bioactive form of the steroid hormone progesterone, presented in its fundamental powdered state. It is the critical active pharmaceutical ingredient (API) sourced before it is formulated into final products like capsules, injections, creams, or suppositories. This raw material is typically synthesized from plant sterols, such as diosgenin found in wild yams or soy, through a process called semi-synthesis. This ensures a bio-identical hormone-meaning its molecular structure is identical to the progesterone produced naturally by the human corpus luteum and placenta.

    Its existence as a "raw material" is pivotal for pharmaceutical compounding pharmacies and manufacturers. It provides the foundational building block from which tailored hormone replacement therapies (HRT) and fertility treatments are created, allowing for precise dosing and specific delivery mechanisms suited to individual patient needs in maintaining pregnancy.

    The efficacy of progesterone raw material powder is defined by its distinct features:

    ●High Purity (>99%): As an API, it undergoes rigorous purification processes to eliminate impurities and related substances, ensuring pharmacological efficacy and reducing the risk of adverse reactions.

    ●Bio-Identical Molecular Structure: Unlike synthetic progestins (e.g., medroxyprogesterone acetate), its structure is a perfect match to endogenous human progesterone. This allows it to bind naturally and effectively to progesterone receptors in the body, eliciting the desired physiological responses without the androgenic or glucocorticoid side effects often associated with synthetics.

    ●White to Off-White Crystalline Powder: Its physical form is a fine, free-flowing powder, which is stable, has a long shelf life, and is easily soluble in oils (for injectables) and compatible with various excipients for oral and topical formulations.

    ●Lipophilic Nature: Being fat-soluble, it is perfectly suited for transmucosal (vaginal/rectal) and transdermal delivery, allowing for direct absorption into the bloodstream while bypassing first-pass liver metabolism, which is crucial for achieving high serum levels.

    The primary application of this raw material, once formulated, is in reproductive medicine to sustain a pregnancy, particularly in cases of inherent hormonal insufficiency. Its applications are targeted and critical:

    ●Luteal Phase Support: The most common application. Following ovulation, the corpus luteum produces progesterone to prepare and maintain the uterine lining (endometrium). A luteal phase defect (LPD) occurs when progesterone production is inadequate, making implantation difficult or leading to early pregnancy loss. Supplemental progesterone, derived from the raw powder, is administered to correct this defect.

    ●Assisted Reproductive Technology (ART): In IVF (In Vitro Fertilization) and FET (Frozen Embryo Transfer) cycles, the hormonal protocols used to stimulate egg production often suppress the body's natural luteal function. Therefore, progesterone supplementation is not just beneficial but mandatory to create a receptive endometrial environment and support the early pregnancy until the placenta can take over progesterone production (around weeks 8-12).

    ●Recurrent Pregnancy Loss (RPL): For women with a history of unexplained miscarriages, some etiologies are linked to immunological factors or inadequate endometrial development, both of which can be mitigated by progesterone's immunomodulatory and uterine-quieting (smooth muscle relaxant) effects.

    ●Threatened Miscarriage: In cases of early pregnancy bleeding with a confirmed viable intrauterine pregnancy, progesterone supplementation may be used to support the pregnancy and prevent its progression to a complete miscarriage.

    The benefits of using a bio-identical form are specific and significant:

    ●Promotes Uterine Quiescence: It downregulates the expression of oxytocin receptors and inhibits the formation of gap junctions in the myometrium (uterine muscle), effectively preventing premature contractions and protecting the developing fetus.

    ●Endometrial Support and Decidualization: It transforms the estrogen-primed endometrium into a rich, secretory, and receptive state-a process called decidualization-which is essential for embryo implantation and the establishment of a nutrient-rich environment for the fetus.

    ●Immunological Modulation: Progesterone induces the production of a crucial protein called Progesterone-Induced Blocking Factor (PIBF). PIBF modulates the maternal immune response, shifting it from a pro-inflammatory (Th1) response, which could reject the embryo as a foreign body, to an anti-inflammatory (Th2) response, facilitating immune tolerance and acceptance of the semi-allogeneic fetus.

    ●Cervical Integrity: It helps maintain the integrity and rigidity of the cervix, preventing premature shortening and dilation.

    It is imperative to understand that the raw material powder is not for direct human consumption. Its dosage is determined during the pharmaceutical formulation process. The following information pertains to the final products compounded from this raw material.

    ●Dosage: Dosage is highly individualized and dictated by a fertility specialist or obstetrician. Common doses range from 200mg to 800mg per day, often divided into multiple administrations.

    ●Administration Routes:

    ○Vaginal: The most common route for fertility support (e.g., suppositories, gels, inserts). It provides direct uterine delivery ("first-uterus pass effect") with high local tissue concentration and lower systemic side effects like drowsiness.

    ○Intramuscular (IM) Injection: A traditional method using oil-based solutions. It provides very reliable and high serum levels but can be painful and may cause injection site reactions.

    ○Oral: Requires micronization (finely ground) for absorption and is formulated with oils. It undergoes first-pass liver metabolism, leading to variable serum levels and a higher incidence of side effects like sedation and dizziness.

    ●Cycle/Timing: Supplementation almost always begins shortly after egg retrieval (in IVF) or after confirmation of ovulation (in natural/IUI cycles). It continues steadily throughout the first trimester, typically until week 10-12 of gestation, when the placenta becomes the primary source of progesterone. A blood test is often performed to confirm sufficient placental takeover before tapering the dose, which is done gradually under medical supervision to avoid a sudden hormonal drop.

    The half-life varies significantly based on the route of administration, which is why dosing frequency is route-dependent.

    ●Oral Micronized Progesterone: Has a short serum half-life of approximately 5-20 hours. Its metabolites have even shorter half-lives, necessitating multiple daily doses (e.g., 2-3 times per day).

    ●Vaginal Progesterone: Pharmacokinetics are complex. While its serum half-life is similar to the oral form, its therapeutic effect in the uterus is prolonged due to direct tissue absorption. Serum levels may appear low, but uterine tissue concentrations are high, making serum monitoring less useful for vaginal administration.

    ●Intramuscular Progesterone: Has a much longer and sustained release pattern, with a half-life ranging from 22-28 hours. This allows for once-daily dosing.

    In this context, PTC stands for "Pregnancy Termination Concern." This is a paramount concept that must be clearly understood to counter misinformation.

    Progesterone is NOT an abortifacient and will not terminate a viable intrauterine pregnancy. Its mechanism of action is to sustain the uterine lining and support the pregnancy.

    The concern arises from the use of progesterone receptor antagonists like Mifepristone (RU-486), which are used in medical abortions. These drugs block the progesterone receptor, effectively inducing a miscarriage by reversing progesterone's supportive effects.

    Therefore, supplemental bio-identical progesterone, derived from the raw material powder, has the opposite effect. It is a vital life-supporting intervention for at-risk pregnancies. The "Pregnancy Termination Concern" is a misconception; the true concern is the absence of progesterone, not its presence. Administering it under medical guidance poses no risk of terminating a healthy pregnancy and is, in fact, a primary tool for preventing miscarriage.

Trade names	Crinone, Endometrin,progesterone,4-pregnene-3,20-dione,P4
CAS	57-83-0
Molar mass	314.46
MF	C21H30O2
Purity	Above 98%
Apprarance	White crystalline powder

 

 

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-15871669785

   

                                   

 

   Progesterone Raw Material Powder is far more than a simple chemical compound; it is the unsung hero of early gestation. As the purified, bio-identical API, it serves as the essential precursor for life-sustaining therapies. Its role in preparing the endometrium, modulating the immune system, and maintaining uterine tranquility is irreplaceable. Through sophisticated formulations into vaginal, injectable, or oral products, it provides the precise hormonal support required to navigate the critical early weeks of pregnancy, bridging the gap until the placenta can autonomously assume its role. Understanding its features, applications, and the science behind its use-including dispelling myths like PTC-is crucial for appreciating its profound value in the journey to successful childbirth.

Hot Tags: progesterone raw material powder for maintaining pregnancy cas:57-83-0, China progesterone raw material powder for maintaining pregnancy cas:57-83-0 manufacturers, suppliers, factory, Clomid Treatment of female anovulatory infertility, Fluoxymethelone treatment of inflammatory eye diseases, Sustanon, Testosterone Acetate, Testosterone Phenylpropionate, Trenbolone Enanthate